v3.25.2
Debt (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 26, 2025
Sep. 30, 2024
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Feb. 03, 2025
Debt Instrument [Line Items]                    
Long term debt     $ 28,000,000.0   $ 387,000,000.0   $ 387,000,000.0   $ 28,000,000.0  
Long term debt availability     7,200,000   88,000,000.0   88,000,000.0   7,200,000  
Interest expense         8,100,000   1,200,000      
Unamortized deferred financing costs     1,731,000   14,461,000   14,461,000   1,731,000  
Aggregate maximum limit of common stock volume   100.00%   100.00%            
Weighted average interest rate   97.00%   97.00%            
Loss on adjustment to fair value     800,000              
Stock issued during period value conversion of convertible securities           $ 18,164,000        
Principal amount         0   0      
Payment on subordinated note related party             3,214,000    
Subordinated note     4,609,000   1,458,000   1,458,000   4,609,000  
Senior Convertible Note [Member]                    
Debt Instrument [Line Items]                    
Interest rate   8.00%   8.00%            
Maturity date   Sep. 30, 2025                
Unpaid interest rate   105.00%                
Debt principal balance                 11,300,000  
Fair value of convertible debt     12,600,000           12,600,000  
Stock issued during period value conversion of convertible securities           $ 11,300,000        
Stock issued during period value conversion of convertible securities, shares           2,100,000        
Loss on adjustment to fair value debt and warrants             5,500,000      
Subordinated Promissory Note [Member]                    
Debt Instrument [Line Items]                    
Interest rate   10.00%   10.00%            
Maturity date       Mar. 17, 2027            
Principal amount   $ 5,000,000.0   $ 5,000,000.0            
Subordinated Note [Member]                    
Debt Instrument [Line Items]                    
Interest rate 15.00%                  
Principal amount     3,200,000   $ 1,500,000   $ 1,500,000   $ 3,200,000  
Payment on subordinated note related party     $ 1,800,000              
Shares of common stock   1,141,552 570,778 1,141,552 570,778   570,778   570,778  
Fair value of subordinated     $ 4,600,000           $ 4,600,000  
Paid subordinated note amount $ 3,200,000                  
Subordinated note 1,500,000                  
Credit Facility [Member]                    
Debt Instrument [Line Items]                    
Unamortized deferred financing costs     1,700,000   $ 14,500,000   $ 14,500,000   1,700,000  
Minimum [Member]                    
Debt Instrument [Line Items]                    
Commitment fee percentage             0.375%      
Maximum [Member]                    
Debt Instrument [Line Items]                    
Commitment fee percentage             0.50%      
Secured Overnight Financing Rate (SOFR) [Member]                    
Debt Instrument [Line Items]                    
Annum interest rate adjustment percentage             0.10%      
Secured Overnight Financing Rate (SOFR) [Member] | Minimum [Member]                    
Debt Instrument [Line Items]                    
Debt instrument interest rate percentage             2.75%      
Secured Overnight Financing Rate (SOFR) [Member] | Maximum [Member]                    
Debt Instrument [Line Items]                    
Debt instrument interest rate percentage             3.75%      
Alternate Base Rate Loans [Member] | Minimum [Member]                    
Debt Instrument [Line Items]                    
Debt instrument interest rate percentage             1.75%      
Alternate Base Rate Loans [Member] | Maximum [Member]                    
Debt Instrument [Line Items]                    
Debt instrument interest rate percentage             2.75%      
Amended & Restated Credit Facility Agreement [Member]                    
Debt Instrument [Line Items]                    
Borrowing aggregate amount $ 1,000,000,000.0                  
Line of credit facility, expiration date Mar. 26, 2029                  
Line of credit $ 1,000,000,000.0       475,000,000.0   $ 475,000,000.0      
Elected commitment         475,000,000.0   475,000,000.0      
Issuance of letter of credit         47,500,000   $ 47,500,000      
Credit Facility Agreement [Member]                    
Debt Instrument [Line Items]                    
Debt instrument interest rate ratio             Net Leverage Ratio (as defined in the Amended & Restated Credit Agreement) of no greater than 3.00 to 1.00 and a Current Ratio (as defined in the Amended & Restated Credit Agreement) of at least 1.00 to 1.00. The Amended & Restated Credit Agreement also includes conditional equity cure rights that will enable the Company to cure certain breaches of these financial maintenance covenants. Further, beginning April 1, 2025, the Amended & Restated Credit Agreement requires the Company and its restricted subsidiaries to always hedge not less than 80% of projected production from their proved developed producing reserves and certain wells through March 31, 2028.      
Credit Facility Agreement [Member] | Senior Convertible Note [Member]                    
Debt Instrument [Line Items]                    
Payments on senior convertible note     3,700,000              
Standby Equity Purchase Agreement [Member]                    
Debt Instrument [Line Items]                    
Structuring fee   $ 25,000,000                
Commitment fee   100,000                
Common stock limitation description             Any purchases under an Advance will be subject to certain limitations, including that Yorkville cannot acquire (i) any shares that would result in Yorkville, including its affiliates, beneficially owning more than 4.99% of the Company’s outstanding Common Stock at the time of an Advance or (ii) more than 19.99% of the Company’s issued and outstanding Common Stock as of the SEPA Effective Date (the “Exchange Cap”), subject to limited exceptions.      
Standby Equity Purchase Agreement [Member] | Maximum [Member]                    
Debt Instrument [Line Items]                    
Sale of Stock Consideration Received on Transaction   $ 40,000,000.0                
SEPA Registration Rights Agreement [Member]                    
Debt Instrument [Line Items]                    
Borrowing from convertible debt   $ 15,000,000.0   $ 15,000,000.0            
Stock issued during the period             4,198,343      
Fair value     $ 800,000   $ 0   $ 0   $ 800,000  
Loss on adjustment to fair value             $ 800,000      
Bayswater Acquisition [Member]                    
Debt Instrument [Line Items]                    
Borrowing aggregate amount                   $ 60,000,000.0